FindTrial
Sign In

Understanding Steroid Induced Glaucoma and Ocular Hypertension- Causes, Treatment, and Patient Awareness

Steroid induced glaucoma and ocular hypertension- clinical and demographic profile, treatment outcomes and patient awareness about steroids and steroid induced glaucoma- A Prospective Cohort study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086753
Enrollment
173
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H406- Glaucoma secondary to drugs

Interventions

Intervention1: Nil: Nil

Sponsors

Aravind Eye Hospital Pondicherry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Steroid induced ocular hypertension a.IOP greater than 21mmHg with open angles b.history of steroid usage and c.without glaucomatous optic disc damage and visual field changes 2.Steroid induced glaucoma a.presence of open angles with IOP greater than 21 mmHg or IOP smaller than 21 mmHg with AGM started elsewhere for SIG b.glaucomatous optic nerve head changes and corresponding visual field defects on Humphrey 24-2 test

Exclusion criteria

Exclusion criteria: 1.Presence of any other cause which can increase IOP 2.All POAG and NTG 3.All secondary open angle glaucoma other than steroid induced glaucoma 4.Active uveitis 5.Intra-operative complications 6.Presence of greater than 180 degrees of peripheral anterior synechiae 7.Immediate post-operative rise in IOP within 2 weeks

Design outcomes

Primary

MeasureTime frame
To assess the clinical and demographic profile of steroid induced glaucoma and steroid induced ocular hypertension.Timepoint: Day 0 Day 10 Day 30 Day 90—

Secondary

MeasureTime frame
To study the short-term treatment outcomes following the diagnosis of either steroid induced glaucoma/ocular hypertension.Timepoint: Day 0 Day 10 Day 30 Day 90;To assess awareness regarding steroid use & risk associated with it using a questionnaire.Timepoint: Day 0—

Countries

India

Contacts

Public ContactDr. Zenia Sapra

Aravind eye hospital

kavitha@aravind.org9894611575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026